schizandrin b has been researched along with oxidopamine in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | schizandrin b (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, Q; Cui, C; Feng, S; Wen, L; Yang, K; Zhou, J | 1 |
1 other study(ies) available for schizandrin b and oxidopamine
| Article | Year |
|---|---|
Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway.
Topics: 3' Untranslated Regions; Animals; Behavior, Animal; Binding Sites; Brain; Cell Line, Tumor; Cell Survival; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Male; Mice, Inbred C57BL; MicroRNAs; Motor Activity; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Parkinsonian Disorders; Polycyclic Compounds; Signal Transduction; Transfection | 2015 |